Marcum
MicroCap Conference Showcases Technology, Biotech and Health and Wellness Companies
Point
Roberts, WA, June 13, 2016 – Investorideas.com, a global news source and
investor resource covering actively traded sectors reports on the recent 5th
Annual Marcum MicroCap Conference held June 1- June 2, 2016, in New York City
at the Grand Hyatt Hotel.
The two-
day conference presented a cross section of companies in Technology, Media
& Internet, Software & Business Services, Life Science & Healthcare,
Retail & Consumer Products, Energy & Natural Resources, Industrials and
Financials & Asset Management Services
The
Marcum MicroCap Conference is dedicated to providing a forum where publicly
traded companies with less than $500 million in market capitalization can
network with the investment community. The 2016 Conference will be two full
days with feature presentations by CEOs and CFOs from seven principal industry
sectors, expert panels moderated by industry leaders, and the opportunity to
meet with management of presenting companies on a one-on-one basis.
Gino
Pereira, Chief Executive Officer of NXT-ID,
Inc. (NasdaqCM: NXTD) shows
investors its payment technology portfolio including the Wocket smart wallet
and the new smart card being developed for WorldVentures. The SmartCard is
being customized exclusively for WorldVentures DreamTrips Members, currently
numbered at over 500,000 worldwide and growing.
NXT-ID, Inc. (NasdaqCM:NXTD) is an emerging growth technology company that is focused on products,
solutions, and services for security on mobile devices. Our core technologies
consist of those that support digital payments, biometric identification,
encryption, sensors, and miniaturization. We have three distinct lines of
business that we are currently pursuing: mobile commerce, primarily through the
application of secure digital payment technologies; biometric access control
applications, and Department of Defense contracting. Our initial efforts have
primarily focused on the development of our secure products for the growing
m-commerce market, most immediately, a secure mobile electronic smart wallet,
the Wocket®. The Wocket® is a smart wallet, designed to protect your identity. www.nxt-id.com, www.wocketwallet.com
Dr.
Sergio Traversa PharmD, MBA, CEO of
Relmada Therapeutics (OTC:RLMD) said at the conference, “One thing that I have
learned and I am strongly convinced about I; is that to make a biotech or
pharmaceutical company successful, you need three components: you need the science, you need the capital
and you need the people…and if I had to pick one of these three components to
be successful, I will always give you the same answer, and it is the people.”
Mr.
Denis Corin, President of Q BioMed Inc. (OTCQB: QBIO) presented his company’s mission to license and acquire innovative life sciences assets from academia or
small private companies,
Mr.
Denis Corin, President of Q BioMed Inc.
About Q
BioMed Inc. (OTCQB: QBIO)
Q BioMed Inc. ("Q") is a biomedical
acceleration and development company. We are focused on acquiring companies and
biomedical assets. Q is dedicated to providing these target companies and
assets, strategic resources, developmental support, and expansion capital to
ensure they meet their developmental potential enabling them to provide
products to patients in need.
Relmada
Therapeutics (OTC:RLMD) is a clinical-stage, publicly traded specialty
pharmaceutical company developing novel versions of proven drug products
together with new chemical entities that potentially address areas of high
unmet medical need in the treatment of pain. The Company has a diversified
portfolio of four lead products at various stages of development including
LevoCap ER, its abuse resistant, sustained release dosage form of the opioid
analgesic levorphanol; d-methadone, its N-methyl-D-aspartate (NMDA) receptor
antagonist for neuropathic pain; BuTab ER, its oral dosage form of the opioid
analgesic buprenorphine; and MepiGel, its orphan drug designated topical
formulation of the local anesthetic mepivacaine. The Company’s product
development efforts are guided by the internationally recognized scientific
expertise of its research team. The Company’s approach is expected to reduce
clinical development risks and costs while potentially delivering valuable
products in areas of high unmet medical needs. www.relmada.com Investor presentation available at http://content.stockpr.com/relmada/db/184/662/pdf/Relmada_Corporate_Presentation_June2016_finalv2.pdf
Rod
A. Smith, CEO/Founder of Green PolkaDot Box Incorporated (GPDB) talked
about their non-GMO product lines and their goal to make healthy food
affordable to America.
Green
PolkaDot Box® is America's "first mover" online U.S. distributor of
CLEAN foods. Green PolkaDot Box (“GPDB” or the Company), a publicly traded
company (OTC: GPDB), is an online food distributor that is solving enormous
food problems in the United States: (1) the high cost and limited availability
of CLEAN foods; and (2) the proliferation of GMO contaminated foods that have
pervaded more than 70% of the food supply.
GREEN
POLKADOT BOX INCORPORATED’s mission is to educate, inform consumers about the
links between a poor diet and chronic illness and disease and deliver CLEAN
foods to millions of U.S. households at wholesale pricing with FREE home
delivery; both services provided through a network of thousands of influential
Health Merchants; and to employ sustainable business practices for a healthier
America while conserving the Earth’s natural environment
Michael DePasquale CEO of BIO-key International presented his company’s biometric technology. BIO-key (OTC: BKYI) headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world.
Some
other companies presenting included:
Tecogen Inc. (NasdaqCM:TGEN) designs, manufactures, sells, installs, and maintains high efficiency,
ultra-clean, cogeneration products including natural gas engine-driven combined
heat and power, air conditioning systems, and high-efficiency water heaters for
residential, commercial, recreational and industrial use. The company is known
for cost efficient, environmentally friendly and reliable products for energy
production that, through patented technology, nearly eliminate criteria
pollutants and significantly reduce a customer's carbon footprint. In business
for over 20 years, Tecogen has shipped more than 2,300 units, supported by an
established network of engineering, sales, and service personnel across the
United States.
Coffee Holding Company, Inc. (NasdaqCM:JVA) is a leading integrated
wholesale coffee roaster and dealer in the United States and one of the few
coffee companies that offers a broad array of coffee products across the entire
spectrum of consumer tastes, preferences and price points. Coffee Holding has
been a family-operated business for three generations and has remained
profitable through varying cycles in the coffee industry and the economy. The
Company's private label and branded coffee products are sold throughout the
United States, Canada and abroad to supermarkets, wholesalers, and individually
owned and multi-unit retail customers.
Fuling Global Inc. (NasdaqCM:FORK) is a specialized producer
and distributor of environmentally friendly plastic serviceware, with precision
manufacturing facilities in both the U.S. and China. The Company's plastic
serviceware products include disposable cutlery, drinking straws, cups, plates
and other plastic products and are used by more than one hundred customers
primarily from the U.S. and Europe, including Subway, Wendy's, Burger King, KFC
(China only), Walmart, McKesson, and Woolworths.
Dataram Corporation (NasdaqCM:
DRAM) is
a leading independent manufacturer of memory products and provider of performance
solutions that increase the performance and extend the useful life of servers,
workstation, desktops and laptops sold by leading manufacturers such as Dell,
Cisco, Fujitsu, HP, IBM, Lenovo and Oracle. Dataram's memory products and
solutions are sold worldwide to OEMs, distributors, value-added resellers and
end users. Additionally, Dataram manufactures and markets a line of Intel
Approved memory products for sale to manufacturers and assemblers of embedded
and original equipment. 70 Fortune 100 companies are powered by Dataram.
Founded in 1967, the Company is a US based manufacturer, with presence in the
United States, Europe and Asia.
IZEA Inc. (NasdaqCM:
IZEA) operates
IZEAx, the premier online marketplace that connects brands with influential
content creators. IZEA creators range from leading bloggers and social media
personalities to A-list celebrities and professional journalists. Creators are
compensated for developing and distributing unique content on behalf of brands
including long form text, videos, photos and status updates. Brands receive
influential consumer content and engaging, shareable stories that drive
awareness.
Capnia, Inc. (NasdaqCM:CAPN) is a
diversified healthcare company that develops and commercializes innovative
diagnostics, devices and therapeutics addressing unmet medical needs. Capnia's
lead commercial product, CoSense, is based on the Sensalyze™ Technology
Platform. It is a portable, non-invasive device that rapidly and accurately
measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance
for sale in the U.S. and has received CE Mark certification for sale in the
European Union. CoSense is used for the monitoring of CO from internal sources
(such as hemolysis, a dangerous condition in which red blood cells degrade
rapidly), as well as external sources (such as CO poisoning and smoke
inhalation). The initial target market is newborns with jaundice that are at
risk for hemolysis, comprising approximately three million births in the U.S.
and European Union. The Company's commercial, neonatology-focused product line also
includes innovative pulmonary resuscitation solutions, including the NeoPIP™
Infant T-Piece Resuscitator and Universal T-Piece Circuit consumables. Serenz
Allergy Relief is Capnia’s proprietary commercial product that uses nasal,
non-inhaled CO2 to relieve nasal allergy symptoms such as
congestion, sneezing, itchy and runny nose. The nasal, non-inhaled CO2
therapeutic technology is also being evaluated to treat trigeminally-mediated
pain conditions such as cluster headache, trigeminal neuralgia, and migraine.
Pulmatrix (NasdaqGM:PULM) is a
clinical stage biopharmaceutical company developing innovative inhaled
therapies to address serious pulmonary disease using its patented iSPERSE™
technology. The Company's proprietary product pipeline is focused on advancing
treatments for rare diseases, including PUR1900, an inhaled anti-fungal for
lung disease patients. In addition, Pulmatrix is pursuing opportunities in
major pulmonary diseases through collaborations, including PUR0200, a branded
generic in clinical development for chronic obstructive pulmonary disease
(COPD). Pulmatrix's product candidates are based on iSPERSE™, its
proprietary dry powder delivery platform, which seeks to improve therapeutic
delivery to the lungs by maximizing local concentrations and reducing systemic
side effects to improve patient outcomes.
See
a full list of presenting companies: http://www.marcumllp.com/MicroCap/presenting-companies
Read this release in full
and view images at http://www.investorideas.com/news/2016/main/06131.asp
About
Investorideas.com - News that Inspires Big Ideas
Sectors
we cover in include mining, energy, renewable energy, water stocks, food and
beverage (including organic and LOHAS, wine), defense and security, biotech,
technology and mobile. We have also expanded our global coverage to include
Latin American stocks, the Middle East, sports and entertainment.
Investor Ideas
Directories for global investors:
From
water stocks to gold and mining stocks, renewable energy, nanotech, defense,
technology, biotech and more – use our stock directories and access them online
24/7 with login as a member to find your next big idea!
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: As of October 1, 2015 NXT-Id
renewed for one year –five thousand per month and fifteen thousand 144
restricted shares for PR, media and marketing . QBIO is a former advertiser
/client on Investorideas.com http://www.investorideas.com/About/News/Clientspecifics.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Contact
Investorideas.com
800-665-0411
Great article, I would love to be able to sit in on that conference. Too bad its extremely difficult to get a seat.
ReplyDelete